Clinical Edge Journal Scan

Clinical Edge Journal Scan

Sustained glycemic control in T2D decreases the likelihood for long-term complications

Publish date: April 12, 2022

• Read More

Clinical Edge Journal Scan

Severe mental illness raises risk for serious long-term diabetic complications in T2D

Publish date: April 12, 2022

• Read More

Clinical Edge Journal Scan

Preadmission antidiabetic drug use and mortality risk in COVID-19 patients with T2D

Publish date: April 12, 2022

• Read More

Clinical Edge Journal Scan

SGLT2is offers real-world renal protective benefits over DPP4i in T2D

Publish date: April 12, 2022

• Read More

Clinical Edge Journal Scan

Resistance training reduces HbA1c levels in patients with T2D

Publish date: April 12, 2022

• Read More

Clinical Edge Journal Scan

Fenofibrate improves heart failure outcomes in patients with T2D treated with simvastatin

Publish date: April 12, 2022

• Read More

Clinical Edge Journal Scan

T2D: Empagliflozin improves cognitive and physical function in older adults with HFpEF

Publish date: April 12, 2022

• Read More

Clinical Edge Journal Scan

Dapagliflozin shows promise in young people with T2D in phase 3

Publish date: April 12, 2022

• Read More

Pages

• « first
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8